- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | Adia Med Inc.: Adia Med Reports No Serious Adverse Events in First Cohort of Pediatric Autism Study; Enrollment Continues | 229 | Newsfile | No serious adverse events reported in either study arm; enrollment and participant follow-up continueWinter Park, Florida--(Newsfile Corp. - October 26, 2026) - Adia Med Inc. (OTCQB: ADIA) today reported... ► Artikel lesen | |
| 20.10. | Adia Med Inc.: Adia Med Sells 7% Economic Interest in Adia Labs to CEO Larry Powalisz for $350,000 in Cash | 313 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 20, 2026) - Adia Med, Inc. (OTCQB: ADIA) today announced that its Chief Executive Officer, Larry Powalisz, purchased a 7% economic interest in Adia Labs... ► Artikel lesen | |
| ADIA MED Aktie jetzt für 0€ handeln | |||||
| 13.10. | Adia Med Inc.: Adia Med Fully Repays Related-Party Credit Facility, Strengthening Its Financial Position | 301 | Newsfile | Full repayment eliminates the Company's unsecured revolving credit facility and simplifies its remaining obligationsWinter Park, Florida--(Newsfile Corp. - October 13, 2026) - Adia Med, Inc. (OTCQB:... ► Artikel lesen | |
| 13.10. | Adia Med, Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.10. | Adia Med Inc.: Adia Med Partners with Live Oak Health (dba QCM Biologics) as Distributor and Sells 30% Stake in Adia Labs for $1.5 Million | 581 | Newsfile | Winter Park, Florida--(Newsfile Corp. - October 6, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced that it has sold a 30% interest in Adia Labs LLC to Live Oak Health, a stem cell distributor doing... ► Artikel lesen | |
| 05.10. | Adia Med, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 29.09. | Adia Med Inc.: Adia Med Inc. Announces Adia Labs Expansion of Regenerative Product Line | 264 | Newsfile | New research-use products - Adia30M, AdiaClear, and AdiaEXO - give physicians more options in cell count, format, and concentration for investigational studies.Winter Park, Florida--(Newsfile Corp.... ► Artikel lesen | |
| 22.09. | Adia Med Inc.: Adia Med Inc. Announces Adia Labs Biologic Inventory Now Exceeds $1.5 Million to Meet Rising Demand for the Company's Biological Products | 294 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 22, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and physician-supervised investigational... ► Artikel lesen | |
| 15.09. | Adia Med submits fifth clinical study protocol for 2026 | 2 | Investing.com | ||
| 15.09. | Adia Med Inc.: Adia Med Submits Fifth 2026 Clinical Study to IRB: Osteoarthritis Protocol for One-Time Systemic Treatment | 180 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 15, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company, today announced that its subsidiary, Adia Med of Winter Park, LLC, has submitted... ► Artikel lesen | |
| 08.09. | Adia Med Inc.: Nasdaq Shareholder Requirements Just Verified By Adia Med | 290 | Newsfile | Winter Park, Florida--(Newsfile Corp. - September 8, 2026) - Nasdaq requires companies seeking an initial listing on the Nasdaq Capital Market to have a sufficiently broad public shareholder base. That... ► Artikel lesen | |
| 24.08. | Adia Med engages law firm for planned Nasdaq uplisting | 3 | Investing.com | ||
| 24.08. | Adia Med Inc.: Adia Med Inc. Engages Lucosky Brookman LLP as Legal Counsel for Planned NASDAQ Uplisting | 352 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 24, 2026) - Adia Med Inc. (OTCQB: ADIA) today announced that it has entered into an engagement letter with Lucosky Brookman LLP ("Lucosky Brookman")... ► Artikel lesen | |
| 17.08. | FINRA genehmigt Umfirmierung: Adia Nutrition wird zu Adia Med | 1 | Investing.com Deutsch | ||
| 17.08. | Adia Nutrition, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 14.08. | Adia Med reports Q2 results | 1 | Seeking Alpha | ||
| 13.08. | Adia Med Inc.: Adia Med Delivers Record Q2 Results: $485K Revenue, First Net Profit, and Nearly Matches Full-Year 2025 Revenue in First Half | 664 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 13, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies, biologics, and advanced clinical services... ► Artikel lesen | |
| 13.08. | Adia Nutrition, Inc. - 10-Q, Quarterly Report | 5 | SEC Filings | ||
| 11.08. | Adia Med Inc.: Adia Med Partners with Full Sail University; CEO Larry Powalisz to Present Company and Explore Student Assistance with SEO, Social Media, and Marketing | 285 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 11, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced a new educational... ► Artikel lesen | |
| 05.08. | Adia Med Inc.: Adia Med to Host Dinner for Physicians at Christner's Steakhouse on August 5 to Discuss Clinical Studies and Collaboration Opportunities | 613 | Newsfile | Winter Park, Florida--(Newsfile Corp. - August 5, 2026) - Adia Med Inc. (OTCQB: ADIA), a regenerative medicine company focused on stem cell therapies and biologics, today announced that it will... ► Artikel lesen |
1 2 3 4 Weiter >>
71 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 42,890 | 0,00 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,400 | -2,58 % | JPMORGAN stuft FMC FRESENIUS MEDICAL CARE AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat FMC auf "Underweight" mit einem Kursziel von 32,30 Euro belassen. Entgegen seinen Erwartungen seien die Konsensschätzungen an die Quartalszahlen... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 66,97 | +0,12 % | BrightSpring Health Q3 2026 Earnings Call Transcript | ||
| FRESENIUS | 47,795 | +1,69 % | BERENBERG stuft Fresenius SE auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius von 50 auf 54 Euro angehoben und die Einstufung auf "Buy" belassen. Der Markt bewerte den Medizinkonzern als vom... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 7,280 | +0,14 % | Piper Sandler cuts Alignment Healthcare stock price target on weak guidance | ||
| HEARTFLOW | 59,11 | +0,10 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| GERRESHEIMER | 32,040 | +0,44 % | Kurssprünge und neue Aufträge: Wie belastbar ist die Wende? dynaCERT, Gerresheimer, Steyr Motors | Ein Übernahmeangebot, internationale Vertriebsfortschritte und ein Konzernumbau bringen Bewegung in die folgenden drei Börsenwerte. Während Anleger auf neue Wachstumsimpulse und finanzielle Entlastung... ► Artikel lesen | |
| GENEDX | 69,04 | -0,03 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| CARL ZEISS MEDITEC | 34,980 | +0,63 % | JPMORGAN stuft CARL ZEISS MEDITEC AG auf 'Underweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat Carl Zeiss Meditec auf "Underweight" mit einem Kursziel von 18,10 Euro belassen. Für die Quartalszahlen am 10. Dezember liege er beim Umsatz auf... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,410 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| PROGYNY | 29,210 | +0,07 % | Progyny, Inc.: New Progyny Study Examines Persistent Racial and Ethnic Differences in Fertility Treatment Initiation Despite Access to Benefits | ||
| BETA BIONICS | 16,730 | -0,12 % | Truist reiterates Buy on Beta Bionics stock, $28 target on MINT | ||
| BILLIONTOONE | 113,21 | -0,10 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| DRAEGERWERK | 102,00 | -3,23 % | EQS-DD: Drägerwerk AG & Co. KGaA: Dr. Heinrich Dräger GmbH, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
28.10.2026 / 11:57... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 21,490 | +0,05 % | Privia Health Group, Inc.: Privia Health Announces Appointment of Opella Ernest, M.D. to its Board of Directors | ARLINGTON, Va., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced the appointment of Opella Ernest, M.D. to its Board of Directors, effective September 1, 2026.... ► Artikel lesen |
ADIA MED INC gehört der Branche Gesundheitswesen an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ADIA MED INC finden Sie auf Wallstreet Online.